海外の骨肉腫専門医 — ページ5

Orthopedist, Oncologist, Specialist in osteosarcoma treatment

Prof. Bernd Hertenstein is a clinical oncologist at Bremen-Mitte Clinic. He is the Head of the Cancer Center and Chief Physician. Hertenstein treats complex cancers and performs bone marrow transplantation. He provides chemotherapy and radiotherapy for cancer patients.

Clinical Focus and Techniques

Hertenstein treats a range of oncological and hematological conditions. He treats cancers including leukemia, Hodgkin's lymphoma, and lung cancer. The doctor performs several types of bone marrow and stem cell transplants:

• Autologous bone marrow transplantation
• Allogenic bone marrow transplantation from related donors
• Allogenic bone marrow transplantation from unrelated donors

He also uses targeted therapies for liver and breast cancer. He performs radiofrequency ablation and chemoembolization of the liver. These techniques use heat or localized drugs to destroy tumors. He also conducts marrow biopsies and cytogenetic studies — the analysis of chromosomes to identify genetic mutations.

Conditions Treated

• Acute lymphoblastic leukemia and other leukemias
• Non-Hodgkin's and follicular lymphoma
• Liver and stomach cancer
• Aplastic anemia and myeloma
• Testicular and bone cancer
• Metastases in the liver

Professional Roles and Research

Hertenstein leads the oncology department at Bremen-Mitte Clinic in Germany. This hospital was a medical institution featured by Focus magazine in 2016. He has contributed to numerous medical publications. This research helps advance oncological care and radiotherapy protocols.

Academic and Professional Memberships

Prof. Hertenstein holds the following positions and qualifications:

• Clinical Oncologist
• Head of Cancer Center
• Chief Physician at Bremen-Mitte Clinic
• Contributor to numerous publications

医師はShyam Shah Medical Collegeで内科の医学博士号を取得し、同部門でシニアレジデンシーを務めました。その後、Jawaharlal Nehru Cancer Hospitalで医療腫瘍学のレジストラとして勤務しました。医師はIndraprastha Apollo Hospitalで医療腫瘍学のDNBトレーニングを修了しました。

シニアレジデンシーの期間中、医師はAIIMSで開催されたInternational Winter School of Oncologyで講義を行い、American Society of Clinical OncologyによるGastrointestinal Cancer Symposiumで胃がんに関する研究を発表しました。医師はがんの分子基盤と標的療法を専門としています。